Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 21, 2024
Finance

Public Equity Report: Cinclus dips after pricing Stockholm IPO

Plus: Tectonic arrives on NASDAQ; UroGen prices offering amid rolling NMIBC submission
BioCentury | Mar 15, 2010
Regulation

IPF pipeline

BioCentury | Mar 23, 2009
Clinical News

Compugen preclinical data

Items per page:
1 - 5 of 5